This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Enbrel
  • /
  • A 12-Week Multicenter, Randomized, Double-Blind, P...
Clinical trial

A 12-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of LY2439821 to Etanercept and Placebo in Patients With Moderate to Severe Plaque Psoriasis With a Long-Term Extension Period

Read time: 2 mins
Last updated:1st Jul 2012
Identifier: NCT01646177
This study will assess the safety and efficacy of ixekizumab (LY2439821), compared to etanercept and placebo in participants with moderate to severe chronic plaque psoriasis.

 

Category Value
Date last updated at source 2016-08-27
Study type(s) Interventional
Expected enrolment 1346
Study start date 2012-07-01
Estimated primary completion date 2019-08-01

View full details